Universal-Beteiligungs- und Servicegesellschaft
CTKB icon

Universal-Beteiligungs- und Servicegesellschaft’s Cytek Biosciences CTKB Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,873
Closed -$87.7K – 2025
2025
Q1 		$87.7K Hold
21,873
– – ﹤0.01% 1953
2024
Q4 		$142K Buy
+21,873
New +$130K ﹤0.01% 1002

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CTKB Position: Q2 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Cytek Biosciences (CTKB) in Q2 2025, closing a stake of 21,873 shares — an estimated $87.7K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CTKB in Q4 2024 and held it in 2 quarters. The position peaked at $142K in Q4 2024. 158 funds tracked by Wall St. Rank hold CTKB as of Q2 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Cytek Biosciences position as of Q2 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 21,873 Cytek Biosciences shares in Q2 2025, an estimated $87.7K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Cytek Biosciences in Q4 2024 and held it in 2 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Cytek Biosciences position peaked at $142K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2025, filed 11 Aug 2025.